Andexanet Alfa for Factor Xa Inhibitor Reversal.

Suppr

超能文献

作者信息

Hunt Beverley J, Levi Marcel

机构信息

Guy’s & St. Thomas’ NHS Foundation Trust, London, United Kingdom

Academic Medical Center, Amsterdam, the Netherlands

出版信息

N Engl J Med. 2016 Dec 22;375(25):2500. doi: 10.1056/NEJMc1613270.

DOI:10.1056/NEJMc1613270

PMID:28009496

Abstract

摘要

相似文献

Andexanet Alfa for Factor Xa Inhibitor Reversal.

N Engl J Med. 2016 Dec 22;375(25):2500. doi: 10.1056/NEJMc1613270.

Andexanet Alfa for Factor Xa Inhibitor Reversal.

N Engl J Med. 2016 Dec 22;375(25):2499-500. doi: 10.1056/NEJMc1613270.

Andexanet Alfa for Factor Xa Inhibitor Reversal.

N Engl J Med. 2016 Dec 22;375(25):2499. doi: 10.1056/NEJMc1613270.

Andexanet Alfa for Factor Xa Inhibitor Reversal.

N Engl J Med. 2016 Dec 22;375(25):2498. doi: 10.1056/NEJMc1613270.

Andexanet Alfa for Factor Xa Inhibitor Reversal.

N Engl J Med. 2016 Dec 22;375(25):2498-9. doi: 10.1056/NEJMc1613270.

Andexanet alfa for the reversal of Factor Xa inhibitor related anticoagulation.

Expert Rev Hematol. 2016;9(2):115-22. doi: 10.1586/17474086.2016.1135046.

Andexanet alfa for the reversal of anticoagulant activity in patients treated with direct and indirect factor Xa inhibitors.

Expert Rev Cardiovasc Ther. 2017 Apr;15(4):237-245. doi: 10.1080/14779072.2017.1305889. Epub 2017 Mar 22.

Transient or extended reversal of apixaban anticoagulation by andexanet alfa is equally effective in a porcine polytrauma model.

Br J Anaesth. 2019 Aug;123(2):186-195. doi: 10.1016/j.bja.2019.04.059. Epub 2019 Jun 13.

Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model.

PLoS One. 2018 Mar 28;13(3):e0195122. doi: 10.1371/journal.pone.0195122. eCollection 2018.

Comment: Andexanet alfa: A Novel Factor Xa Inhibitor Reversal Agent.

Ann Pharmacother. 2019 Nov;53(11):1167. doi: 10.1177/1060028019855160. Epub 2019 May 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Andexanet Alfa for Factor Xa Inhibitor Reversal.

N Engl J Med. 2016 Dec 22;375(25):2500. doi: 10.1056/NEJMc1613270.

Andexanet Alfa for Factor Xa Inhibitor Reversal.

N Engl J Med. 2016 Dec 22;375(25):2499-500. doi: 10.1056/NEJMc1613270.

Andexanet Alfa for Factor Xa Inhibitor Reversal.

N Engl J Med. 2016 Dec 22;375(25):2499. doi: 10.1056/NEJMc1613270.

Andexanet Alfa for Factor Xa Inhibitor Reversal.

N Engl J Med. 2016 Dec 22;375(25):2498. doi: 10.1056/NEJMc1613270.

Andexanet Alfa for Factor Xa Inhibitor Reversal.

N Engl J Med. 2016 Dec 22;375(25):2498-9. doi: 10.1056/NEJMc1613270.

Andexanet alfa for the reversal of Factor Xa inhibitor related anticoagulation.

Expert Rev Hematol. 2016;9(2):115-22. doi: 10.1586/17474086.2016.1135046.

Andexanet alfa for the reversal of anticoagulant activity in patients treated with direct and indirect factor Xa inhibitors.

Expert Rev Cardiovasc Ther. 2017 Apr;15(4):237-245. doi: 10.1080/14779072.2017.1305889. Epub 2017 Mar 22.

Transient or extended reversal of apixaban anticoagulation by andexanet alfa is equally effective in a porcine polytrauma model.

Br J Anaesth. 2019 Aug;123(2):186-195. doi: 10.1016/j.bja.2019.04.059. Epub 2019 Jun 13.

Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model.

PLoS One. 2018 Mar 28;13(3):e0195122. doi: 10.1371/journal.pone.0195122. eCollection 2018.

Comment: Andexanet alfa: A Novel Factor Xa Inhibitor Reversal Agent.

Ann Pharmacother. 2019 Nov;53(11):1167. doi: 10.1177/1060028019855160. Epub 2019 May 29.